Engin Berber

605 total citations
29 papers, 434 citations indexed

About

Engin Berber is a scholar working on Infectious Diseases, Epidemiology and Ecology, Evolution, Behavior and Systematics. According to data from OpenAlex, Engin Berber has authored 29 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 8 papers in Epidemiology and 7 papers in Ecology, Evolution, Behavior and Systematics. Recurrent topics in Engin Berber's work include Vector-Borne Animal Diseases (7 papers), Viral Infections and Vectors (6 papers) and Viral gastroenteritis research and epidemiology (5 papers). Engin Berber is often cited by papers focused on Vector-Borne Animal Diseases (7 papers), Viral Infections and Vectors (6 papers) and Viral gastroenteritis research and epidemiology (5 papers). Engin Berber collaborates with scholars based in United States, Türkiye and India. Engin Berber's co-authors include Barry T. Rouse, Deepak Sumbria, Şükrü Tonbak, Aykut Özdarendeli, Münir Aktaş, Mustafa Ertek, Ahmet Kalkan, İbrahim Sözdutmaz, Yusuf Bolat and Ahmet Kürşat Azkur and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Journal of Virology.

In The Last Decade

Engin Berber

28 papers receiving 419 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Engin Berber United States 12 262 126 88 81 77 29 434
Veronica V. Rezelj France 11 281 1.1× 89 0.7× 142 1.6× 64 0.8× 63 0.8× 18 400
Agnieszka M. Szemiel United Kingdom 10 344 1.3× 117 0.9× 98 1.1× 68 0.8× 41 0.5× 13 478
Kaori Terasaki United States 14 398 1.5× 162 1.3× 103 1.2× 69 0.9× 30 0.4× 24 507
Kwang-Min Yu South Korea 10 266 1.0× 65 0.5× 40 0.5× 57 0.7× 47 0.6× 16 349
Mark Anthony B. Casel South Korea 8 420 1.6× 74 0.6× 76 0.9× 42 0.5× 40 0.5× 18 493
Xiaoyan Zeng China 11 327 1.2× 134 1.1× 61 0.7× 71 0.9× 20 0.3× 19 502
Vinay Shivanna United States 13 386 1.5× 136 1.1× 31 0.4× 79 1.0× 42 0.5× 34 531
Catherine V. Badger United States 14 528 2.0× 118 0.9× 116 1.3× 112 1.4× 74 1.0× 17 668
Jianmin Wu China 14 237 0.9× 116 0.9× 57 0.6× 177 2.2× 61 0.8× 37 673

Countries citing papers authored by Engin Berber

Since Specialization
Citations

This map shows the geographic impact of Engin Berber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Engin Berber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Engin Berber more than expected).

Fields of papers citing papers by Engin Berber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Engin Berber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Engin Berber. The network helps show where Engin Berber may publish in the future.

Co-authorship network of co-authors of Engin Berber

This figure shows the co-authorship network connecting the top 25 collaborators of Engin Berber. A scholar is included among the top collaborators of Engin Berber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Engin Berber. Engin Berber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berber, Engin, et al.. (2025). Elicitation of neutralizing antibodies and IgG4 subclass switching following booster vaccination with ancestral COVID-19 mRNA vaccines does not reduce breakthrough infections. Human Vaccines & Immunotherapeutics. 21(1). 2547517–2547517. 1 indexed citations
2.
Berber, Engin & Ted M. Ross. (2024). Factors Predicting COVID-19 Vaccine Effectiveness and Longevity of Humoral Immune Responses. Vaccines. 12(11). 1284–1284. 7 indexed citations
3.
Berber, Engin, Sachin Mulik, & Barry T. Rouse. (2024). Meeting the Challenge of Controlling Viral Immunopathology. International Journal of Molecular Sciences. 25(7). 3935–3935. 1 indexed citations
4.
Aksoy, Esra, et al.. (2023). In Vitro Antiviral Potential of Cucurbitaceae Ecballium elaterium and Its Extract Containing Protease Inhibitors against Bovine Rotavirus. SHILAP Revista de lepidopterología. 14(4). 2079–2089. 1 indexed citations
5.
Berber, Engin & Barry T. Rouse. (2023). Controlling viral inflammatory lesions by inhibiting fatty acid metabolism. Microbes and Infection. 25(7). 105141–105141. 1 indexed citations
6.
Mulik, Sachin, Engin Berber, Sharvan Sehrawat, & Barry T. Rouse. (2023). Controlling viral inflammatory lesions by rebalancing immune response patterns. Frontiers in Immunology. 14. 1257192–1257192. 5 indexed citations
7.
Berber, Engin, et al.. (2022). A metabolic blueprint of COVID-19 and long-term vaccine efficacy. Drug Metabolism and Personalized Therapy. 38(1). 15–29. 5 indexed citations
8.
Berber, Engin, Deepak Sumbria, Kim M. Newkirk, & Barry T. Rouse. (2021). Inhibiting Glucose Metabolism Results in Herpes Simplex Encephalitis. The Journal of Immunology. 207(7). 1824–1835. 10 indexed citations
9.
Berber, Engin, et al.. (2021). Meta-analysis and comprehensive study of coronavirus outbreaks: SARS, MERS and COVID-19. Journal of Infection and Public Health. 14(8). 1051–1064. 11 indexed citations
10.
Berber, Engin, et al.. (2021). Controlling the Burden of COVID-19 by Manipulating Host Metabolism. Viral Immunology. 35(1). 24–32. 6 indexed citations
11.
Berber, Engin, et al.. (2021). Development of a protective inactivated vaccine against Crimean–Congo hemorrhagic fever infection. Heliyon. 7(10). e08161–e08161. 14 indexed citations
12.
Berber, Engin, Deepak Sumbria, & Barry T. Rouse. (2021). Could targeting immunometabolism be a way to control the burden of COVID-19 infection?. Microbes and Infection. 23(2-3). 104780–104780. 10 indexed citations
13.
Sumbria, Deepak, et al.. (2021). Modulating glutamine metabolism to control viral immuno-inflammatory lesions. Cellular Immunology. 370. 104450–104450. 14 indexed citations
14.
Sumbria, Deepak, et al.. (2021). Virus Infections and Host Metabolism—Can We Manage the Interactions?. Frontiers in Immunology. 11. 594963–594963. 96 indexed citations
15.
Berber, Engin, et al.. (2020). Newly identified Cryptosporidium parvum virus‐1 from newborn calf diarrhoea in Turkey. Transboundary and Emerging Diseases. 68(4). 2571–2580. 6 indexed citations
16.
Sumbria, Deepak, Engin Berber, & Barry T. Rouse. (2019). Factors Affecting the Tissue Damaging Consequences of Viral Infections. Frontiers in Microbiology. 10. 2314–2314. 17 indexed citations
17.
Berber, Engin, Mustafa Ertek, Şükrü Tonbak, et al.. (2013). Pseudo-plaque reduction neutralization test (PPRNT) for the measurement of neutralizing antibodies to Crimean-Congo hemorrhagic fever virus. Virology Journal. 10(1). 6–6. 17 indexed citations
18.
Berber, Engin, Şükrü Tonbak, Münir Aktaş, et al.. (2012). Application of the pseudo-plaque assay for detection and titration of Crimean-Congo hemorrhagic fever virus. Journal of Virological Methods. 187(1). 26–31. 13 indexed citations
19.
Özdarendeli, Aykut, Engin Berber, Kemalettin Aydın, et al.. (2009). The complete genome analysis of Crimean-Congo hemorrhagic fever virus isolated in Turkey. Virus Research. 147(2). 288–293. 41 indexed citations
20.
Berber, Engin. (1987). Kurtuluş’tan Sonra İzmir’de Yunan İşgal Dönemine Tepkiler. DergiPark (Istanbul University). 3(8). 443–460. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Veronica V. Rezelj Breakdown of academic impact, for papers by Agnieszka M. Szemiel Breakdown of academic impact, for papers by Kaori Terasaki Breakdown of academic impact, for papers by Kwang-Min Yu Breakdown of academic impact, for papers by Mark Anthony B. Casel Breakdown of academic impact, for papers by Xiaoyan Zeng Breakdown of academic impact, for papers by Vinay Shivanna Breakdown of academic impact, for papers by Catherine V. Badger Breakdown of academic impact, for papers by Jianmin Wu
Rankless by CCL
2026